| IV-39 Ana Novakovic Simulation based assessment of flat dose regimen of an anti-PDL1 antibody: Case study of avelumab Thursday 15:10-16:40 |
| IV-39 Ana Novakovic Simulation based assessment of flat dose regimen of an anti-PDL1 antibody: Case study of avelumab Thursday 15:10-16:40 |